NCTS Presents: Meet the Professor – Investigating Critical Issues in the Management of Patients with Severe Asthma

Friday, February 28, 2020
6:00 PM – 8:00 PM
Rezaz Pan Mediterranean
28 Hendersonville Road
Asheville, NC 28803

AGENDA

6:00 PM – 6:30 PM       Registration/Dinner Served
6:30 AM – 7:45 PM       Scientific Session
7:45 PM – 8:00 PM       Question & Answer Session

FACULTY

Stephen P Peters, MD, PhD, FAAAAI, FACP, FATS, FCCP, FCPP
Thomas H. Davis Chair in Pulmonary Medicine
Chief, Section on Pulmonary, Critical Care, Allergy, Immunologic Diseases
Wake Forest School of Medicine
Winston-Salem, North Carolina

PROGRAM OVERVIEW

Despite recent advances in our understanding of the pathophysiology of asthma and a corresponding expansion of targeted treatment modalities, severe asthma care continues to be a challenge in clinical practice. This program is designed to address this issue by imparting clinical knowledge and competence to clinicians that will promote comprehensive assessment and highly personalized treatment of patients whose symptoms meet the criteria for severe asthma. In addition, this initiative is also targeted at providing clinicians with guidance on strategies for using phenotypes and biomarkers to identify patient characteristics in practice, decreasing the use of oral corticosteroids (OCS), and optimally managing patients for the best outcomes.

PROGRAM FORMAT

This program will provide a case-based presentation featuring slides and interactive case studies. A question and answer session, hosted by the faculty presenter, will follow at the conclusion of the presentation.

TARGET AUDIENCE

This educational initiative has been designed for allergists, pulmonologists, specialty nurse practitioners and physician assistants, and internal medicine physicians involved in the management of severe asthma.

LEARNING OBJECTIVES

Upon completion of this educational activity, participants should be able to:

  • Review severe asthma phenotypes and endotypes and conduct appropriate biomarker tests to differentiate between phenotypes in patients with severe asthma
  • Evaluate the latest evidence supporting the use of biologic therapies for the management of severe asthma
  • Incorporate into practice the most recent recommendations for the optimal management of patients with severe asthma
  • Implement strategies to minimize the use of OCS in patients with severe asthma

REGISTRATION

There is no registration fee for attending this symposium; however, seating is limited. To register, click the registration buttons on this page or call Integrity Continuing Education, Inc. at 1-855-835-4004.  Preregistration does not guarantee seating. We recommend arriving at the meeting location early.

ACCREDITATION STATEMENT

Integrity Continuing Education, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION

Integrity Continuing Education, Inc. designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.5 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

DISCLOSURE OF CONFLICTS OF INTEREST

Integrity Continuing Education, Inc. requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Integrity Continuing Education, Inc. for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

A detailed disclosure for all persons in control of content, including the faculty presenter, will be provided at the live event.

DISCLAIMER

The information provided at this CME activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options for a specific patient’s medical condition.

 

Provided by Integrity Continuing Education, Inc.

Supported by an educational grant from Sanofi Genzyme and Regeneron Pharmaceuticals.

 

 

Agenda

6:00 PM – 6:30 PM       Registration/Dinner Served
6:30 AM – 7:45 PM       Scientific Session
7:45 PM – 8:00 PM       Question & Answer Session